Smashed Peaches

Drug Research Studies

Oregon measure to legalize magic mushrooms qualifies for November ballot – The GrowthOp

Oregon will vote to legalize the use of therapeutic psilocybin under medical professional supervision this year, after an initiative qualified for the November ballot. If approved, Oregon would become the first state to allow the use of psilocybin, the psychoactive ingredient found in psychedelic mushrooms.

The group behind the ballot question, Initiative Petition 34, collected 164,782 signatures from Oregon residents to put the Oregon Psilocybin Services Act on the ballot. The official amount required to qualify is 112,020 signatures.

“This careful, regulated approach can make a real difference in peoples’ lives and we’re looking forward to bringing this program to the state,” Sheri Eckert said in a statement. Eckert, along with her husband Tom, were chief petitioners on the measure and also founded the Oregon Psilocybin Society.

Back in May, Dr. Bronner’s soap company donated US$1 million to the campaign effort. The company also donated US$150,000 in September 2019.

Dr. Bronner’s supported the ballot initiative because of how the Eckerts constructed the measure. The Oregon Psilocybin Services Act will allow the production, delivery and administration of psilocybin at supervised, licensed facilities. It will also allow a two-year development program to train licensed therapists on psilocybin-assisted treatment.

“We want to make sure it’s done in the right way and we feel that Tom and Sheri are putting forward models based on the best practices based off of the clinical trials coming out of Johns Hopkins and NYU, but making it accessible for everyone,” Dr. Bronner’s CEO David Bronner said in May.

“In many ways, the therapeutic container is like the analog to the indigenous ceremonial container,” Bronner added.

Johns Hopkins researchers have previously called for psilocybin mushrooms to be made legally available for mental health applications. Different studies have found psilocybin significantly reduced depression and anxiety in patients, especially those who had not responded to traditional therapeutic treatment.  A small Johns Hopkins study showed that psilocybin significantly eased depression and anxiety in patients with life-threatening cancer as well.

The, a U.S. lifestyle site that contributes lifestyle content and, with their partnership with 600,000 physicians via Skipta, medical marijuana information to The GrowthOp.

Want to keep up to date on what’s happening in the world of cannabis? Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network